The Truth About SARMs in 2026

The SARM narrative has shifted dramatically. Five years ago, SARMs were the frontier—people treated them as miracle compounds that delivered anabolic effects without testosterone’s downsides. In 2026, the reality is more complicated and honestly, less compelling than the mythology suggested.

I’ve run multiple SARMs. I’ve measured the results. I’ve watched the research evolve. And I need to give you the truth rather than the marketing narrative both the supplement industry and the critics push.

What Are SARMs? The Mechanism

SARM stands for Selective Androgen Receptor Modulator. The theory is elegant: androgens (like testosterone) bind to androgen receptors in multiple tissues—muscle, bone, prostate, liver, cardiovascular system. If you could selectively activate only the muscle and bone androgen receptors while avoiding unwanted effects in other tissues, you’d have the perfect performance enhancement.

That’s the sales pitch. The reality is more complex.

SARMs don’t actually activate receptors selectively in a tissue-specific way at the molecular level. What they do is bind to androgen receptors with different affinities than testosterone and activate them with different tissue distribution and intensity. The “selectivity” is relative and contextual, not absolute. This is a textbook application of the Tony Huge Laws of Biochemistry Physics—receptor affinity and downstream signaling cascades dictate the final physiological outcome, not marketing claims.

This distinction matters because it means SARMs still produce systemic effects—they’re just different from testosterone’s effects.

The Research Reality: What Studies Actually Show

The published research on SARMs in humans is genuinely sparse. Most studies are:

• Short-term (8-12 weeks)
• Small sample sizes (20-50 participants)
• Published by researchers with pharmaceutical company connections
• Measuring relatively modest effects

Here’s what the actual published data shows:

Ostarine (MK-2866): One published human trial showed bone density improvements and modest lean mass gains in older males. Testosterone suppression was present but reversible. Cost: $40-60 monthly.

Ligandrol (LGD-4033): One human study showed lean mass gain of approximately 1.5 lbs over 21 days with minimal side effects. This study was funded by the pharmaceutical company developing it. Real-world results are less dramatic. Cost: $60-80 monthly.

Rad-140: One human study exists, showing benefit for muscle wasting. Long-term safety data is absent. Cost: $80-100 monthly.

YK-11: Essentially zero human safety data. It’s treated almost like an experimental steroid. Cost: $100-150 monthly.

The honest assessment: The clinical evidence for SARMs is underwhelming relative to the marketing hype.

My Personal Testing: The Real Results

I ran ostarine 25mg daily for 8 weeks, measuring everything carefully:

Lean mass gain: Approximately 2.5 lbs over 8 weeks on a slight surplus. This is slower than testosterone microdosing (3-4 lbs) and much slower than Rad-140 or other hardcore SARMs (5-7 lbs).

Strength progression: Modest improvements, nothing dramatic. I gained strength at roughly the same rate as training with good nutrition alone.

Fat loss during cutting: Minimal advantage over baseline. I lost fat at approximately the same rate as without the SARM.

Recovery: Minimal improvement over baseline training.

Testosterone suppression: My testosterone dropped from 450 ng/dL (baseline on no compounds) to 280 ng/dL during the cycle. Recovery took 4 weeks to return to baseline post-cycle. For a compound marketed as “non-suppressive,” this was noteworthy.

Side effects: Minimal. Some mild mood irritability in weeks 4-6, resolved by week 8.

Cost: $360 for the 8-week cycle.

Honest assessment: The SARM produced measurable effects, but they were underwhelming relative to cost and suppression. I achieved better results using a $150 8-week TRT microdose protocol.

Why SARMs Underperform: The Scientific Truth

SARMs activate androgen receptors, but with lower efficacy than testosterone. They’re essentially weaker androgens. Testosterone directly activates AR with high affinity and efficacy. Most SARMs achieve maybe 60-80% of testosterone’s activation intensity.

This means:

• You get 60-80% of testosterone’s anabolic effects
• You still get testosterone suppression (your body shuts down testosterone production when androgen receptors are activated)
• You don’t avoid the need for post-cycle therapy
• You’re paying more for less effect

The marketing premise—”androgens without the downsides”—is scientifically unfounded.

The Suppression Problem: Why This Matters

This is the critical issue no SARM vendor admits: SARMs suppress testosterone. Not to the degree that oral steroids do, but measurably.

Why: Your body produces testosterone in response to luteinizing hormone (LH). When androgen receptors are activated (by SARMs or testosterone), your body sees elevated androgens and suppresses LH production—negative feedback.

If you’re using a SARM, you’re shutting down your testosterone production. When you stop the SARM, your testosterone doesn’t bounce back immediately. It can take weeks to normalize.

This means:

• You need post-cycle therapy (typically nolvadex or clomid)
• You’ll have a suppression period where you feel worse
• Any gains made at the end of the cycle are partially lost as androgens decline post-cycle

For comparison, testosterone suppression is permanent in the context of a cycle—you suppressed your natural production for months, then stop the exogenous testosterone. Recovery is the same: weeks to normalize.

Comparing SARMs to Testosterone

Ostarine 25mg daily vs Testosterone 15mg daily (microdose):

| Metric | Ostarine | Testosterone |

|——–|———-|————–|

| Lean mass gain | 1.5-2 lbs/month | 2.5-3 lbs/month |

| Strength gain | Modest | Moderate |

| Side effects | Minimal | Minimal |

| Suppression | Moderate (~30% drop) | Moderate (~30% drop) |

| Cost | $60/month | $20/month |

| Safety data | Limited | Extensive |

| Post-cycle recovery | 3-4 weeks | 2-3 weeks |

The verdict: Testosterone wins on every metric except perhaps side effect severity (though ostarine’s side effects are minimal). Testosterone costs 1/3 the price, produces better results, and has established safety data.

This is why I don’t run SARMs anymore. I run testosterone instead.

The Suppression Reality Nobody Talks About

Here’s what happens post-SARM:

Weeks 1-2 post-cycle: You feel decent. The SARM is clearing from your system.

Weeks 2-4: Your testosterone is suppressed (your body’s natural production is recovering). You feel terrible—low motivation, low libido, fatigue, mood issues.

Weeks 4-6: Testosterone recovers to baseline. You feel normal again. But you’ve lost some of the gains made during the suppressed recovery phase.

Most people don’t account for this in their cycle planning. They think “8 weeks on ostarine, I gain 8 lbs” without acknowledging “plus 2-3 weeks of suppression where I feel terrible and lose some gains.”

The effective “productive” time on a SARM is compressed because of suppression periods.

Why People Still Use SARMs

If testosterone is cheaper and more effective, why do people use SARMs?

Legality narrative: SARMs exist in a legal gray area. They’re not approved by the FDA, but they’re sold as “research chemicals” without prescription. Some people believe this is “safer” legally, though I’d argue the logic is flawed.

Perceived selectivity: The marketing is powerful. “Muscle without the sides” is attractive, even if scientifically unfounded.

Suppression misconception: People believe SARMs suppress testosterone less than they actually do. This misconception drives continued use.

Availability: SARMs are easy to access online. Testosterone requires either prescription or grey-market sourcing.

The Honest Hierarchy: What Actually Works

If your goal is muscle gain and body composition:

1. Testosterone microdose ($20/month): Best risk-reward ratio. Legal with prescription, extensive safety data, cheaper, more effective.

2. CJC-1295 + GHRP-6 ($25/month): Growth hormone stimulation, legal grey area, very safe, decent effects without suppression.

3. BPC-157 + GHK-Cu ($25/month): Healing and optimization focus, no suppression, legal grey area, synergistic with training.

4. SARMs ($60-100/month): Less effective than testosterone, similar suppression, more expensive, limited safety data.

Testosterone wins when you account for cost, efficacy, safety data, and side effect profile.

The 2026 SARM Update: What’s Changed?

The research has accumulated. We now know:

• SARMs suppress testosterone (this was debated in 2020)
• Efficacy is lower than hyped (long-term studies show modest gains)
• Safety data remains limited (no 2+ year human safety studies)
• Suppression recovery takes weeks (consistent finding)
• Long-term effects unknown (minimal multi-year follow-up data)

The narrative has shifted from “miracle compounds” to “interesting research chemicals with incomplete data.”

My Honest Recommendation

If you’re considering SARMs in 2026:

Skip them. For the same cost or less, run testosterone microdosing with better results and less suppression drama. If you can’t access testosterone, run a peptide stack (CJC-1295 + GHRP-6 + GHK-Cu) for superior long-term health benefits and no suppression.

The only scenario where I’d recommend a SARM: you’re in a jurisdiction where testosterone is genuinely inaccessible and you’re specifically interested in bone density improvement (ostarine has the best research here) without desiring maximal muscle gain.

Even then, I’d validate that testosterone truly isn’t available before committing to a compound with incomplete safety data.

Interesting Perspectives

The conversation around SARMs is evolving beyond simple muscle-building. Some researchers are exploring their potential in niche therapeutic areas where traditional androgens fail. For instance, their tissue selectivity, while imperfect for bodybuilding, may offer advantages in treating conditions like cachexia in cancer patients where prostate stimulation is a major concern with testosterone. There’s also emerging, albeit preliminary, interest in using certain SARMs as neuroprotective agents, leveraging androgen receptor pathways in the brain to potentially slow neurodegenerative decline. This repurposing highlights a key principle: a compound’s value is defined by its application. While SARMs may underwhelm for performance in healthy individuals, their unique pharmacological profile could make them invaluable tools in specific clinical contexts where the risk-benefit calculation is entirely different. This doesn’t excuse the overhyped fitness marketing, but it frames them as specialized research tools rather than general enhancement supplements.

The Bigger Picture

SARMs represent the biohacker version of “sounds good in theory but underwhelms in practice.” The science is incomplete. The results are modest. The suppression is real. The cost is high.

The supplement industry benefits from keeping people cycling between expensive compounds with limited data. Your benefit comes from choosing compounds with established mechanisms, proven results, and cost-effectiveness.

Make data-driven decisions, not hype-driven ones. For a deeper dive into the mechanisms and comparisons, check out our comprehensive SARMs guide and the honest SARMs vs steroids comparison.

For evidence-based protocols using compounds with superior safety data and documented results, visit tonyhuge.is where I detail testosterone optimization, peptide stacking, and integrated biohacking frameworks that actually move the needle on body composition and performance without the suppression drama and incomplete safety profiles.